Publications by authors named "M Craner"

Claim this Profile
E
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Jeremy Chataway, Thomas Williams, James Blackstone, Nevin John, Marie Braisher, Matthew Craner

Lancet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain reserve and physical disability in secondary progressive multiple sclerosis.
Nevin John, Yingtong Li, Floriana De Angelis, Jonathan Stutters, Ferran Prados Carrasco, Matthew Craner

BMJ Neurol Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
James Blackstone, Thomas Williams, Jennifer M Nicholas, Ekaterina Bordea, Floriana De Angelis, Matthew Craner

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of allergens from Aspergillus fumigatus-Potential association with lung damage in asthma.
Eva-Maria Rick, Kerry Woolnough, Matthew Richardson, William Monteiro, Michelle Craner

Allergy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease.
Valentina Camera, Romina Mariano, Silvia Messina, Ricarda Menke, Ludovica Griffanti, Matthew Craner

Brain Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis